Kim Brazzell, MD, PhD

Dr. Brazzell has served as Chief Medical Officer of Kala Pharmaceuticals since February 2013.  He also served as Chief Medical Officer of Mimetogen Pharmaceuticals, from  2012 until  2015. Dr. Brazzell held several executive positions at Inspire Pharmaceuticals, including Executive Vice President and Head of Ophthalmology Business, Executive Vice President of Medical and Scientific Affairs and Senior Vice President of Ophthalmic Research and Development. Prior to joining Inspire, Dr. Brazzell served as Global Head of Clinical R&D and Senior Vice President, U.S. R&D, of Novartis Ophthalmics AG from 2000 to 2004. Dr. Brazzell also served as Vice President, R&D at Ciba Vision Ophthalmics, Inc. and as Associate Director, R&D, at Alcon Laboratories, Inc. Dr. Brazzell received a B.S. in Pharmacy and a Ph.D. in Pharmaceutical Sciences from the University of Kentucky.